A carregar...

Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections

Tedizolid phosphate is the first once-daily oxazolidinone approved by the United States Food and Drug Administration for the treatment of acute bacterial skin and skin structure infections (ABSSSI). It is more potent in vitro than linezolid against methicillin-resistant Staphylococcus aureus (MRSA)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Infect Drug Resist
Main Authors: Hall, Ronald G, Michaels, Heidi N
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4411017/
https://ncbi.nlm.nih.gov/pubmed/25960671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S56691
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!